Cargando…
Dnmt3a Is a Haploinsufficient Tumor Suppressor in CD8+ Peripheral T Cell Lymphoma
DNA methyltransferase 3A (DNMT3A) is an enzyme involved in DNA methylation that is frequently mutated in human hematologic malignancies. We have previously shown that inactivation of Dnmt3a in hematopoietic cells results in chronic lymphocytic leukemia in mice. Here we show that 12% of Dnmt3a-defici...
Autores principales: | Haney, Staci L., Upchurch, G. Michael, Opavska, Jana, Klinkebiel, David, Hlady, Ryan A., Roy, Sohini, Dutta, Samikshan, Datta, Kaustubh, Opavsky, Rene |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5045215/ https://www.ncbi.nlm.nih.gov/pubmed/27690235 http://dx.doi.org/10.1371/journal.pgen.1006334 |
Ejemplares similares
-
Loss of Dnmt3a induces CLL and PTCL with distinct methylomes and transcriptomes in mice
por: Haney, Staci L., et al.
Publicado: (2016) -
Decreases in different Dnmt3b activities drive distinct development of hematologic malignancies in mice
por: Lopusna, Katarina, et al.
Publicado: (2021) -
Catalytically inactive Dnmt3b rescues mouse embryonic development by accessory and repressive functions
por: Nowialis, Pawel, et al.
Publicado: (2019) -
Dnmt3b catalytic activity is critical for its tumour suppressor function in lymphomagenesis and is associated with c-Met oncogenic signalling
por: Lopusna, Katarina, et al.
Publicado: (2021) -
Aberrant Promoter Hypomethylation in CLL: Does It Matter for Disease Development?
por: Upchurch, Garland Michael, et al.
Publicado: (2016)